Filing Details
- Accession Number:
- 0001209191-17-020262
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-13 17:42:15
- Reporting Period:
- 2017-03-10
- Filing Date:
- 2017-03-13
- Accepted Time:
- 2017-03-13 17:42:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604464 | Atara Biotherapeutics Inc. | ATRA | Biological Products, (No Disgnostic Substances) (2836) | 460920988 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612090 | Gad Soffer | 611 Gateway Boulevard Suite 900 South San Francisco CA 94080 | Evp & Chief Strategy Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-03-10 | 2,500 | $20.00 | 266,527 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Transaction pursuant to Rule 10b5-1 Plan adopted September 26, 2016.
Billionaire Hedge Funds
